Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3677 (miR-3677) is a non-coding small RNA molecule classified as a microRNA and involved in the post-transcriptional regulation of gene expression. It is upregulated in various human cancers, including high-grade breast cancer and lung adenocarcinoma, where its expression is associated with more aggressive disease features and poorer prognosis. Functionally, miR-3677 promotes cancer cell proliferation, migration, and invasion. This is likely mediated through negative regulation of tumor suppressor genes such as TLE3 in breast cancer and KLF12 in lung adenocarcinoma[1][2]. In hepatocellular carcinoma and colon cancer, similar oncogenic roles are reported. miR-3677 is under active investigation as a diagnostic and prognostic biomarker for multiple cancers, but is not itself a classic therapeutic target such as a receptor, enzyme, or ion channel[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3677 (miR-3677).